Insider Stock Trading History of Prasad Suyash


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Prasad Suyash since year 2005. The trader's CIK number is 1679129. At the time of this reporting, Prasad Suyash is the Senior VP & Chief Med Officer of Audentes Therapeutics, Inc. . (stock ticker symbol BOLD). See this page for all insider trading activities at Audentes Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Prasad Suyash since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-10-01 BOLD Audentes Therapeutics, Inc. Option Ex 10,000 .79 7,900
2018-10-01 BOLD Audentes Therapeutics, Inc. Sale 10,000 37.62 376,220
2018-07-02 BOLD Audentes Therapeutics, Inc. Option Ex 10,000 .79 7,900
2018-07-02 BOLD Audentes Therapeutics, Inc. Sale 10,000 38.41 384,060
2017-03-29 BOLD Audentes Therapeutics, Inc. Sale 7,800 30.02 234,195
2018-03-29 BOLD Audentes Therapeutics, Inc. Option Ex 7,800 .79 6,162
2018-03-26 BOLD Audentes Therapeutics, Inc. Option Ex 1,900 .79 1,501
2018-03-27 BOLD Audentes Therapeutics, Inc. Option Ex 300 .79 237
2018-03-26 BOLD Audentes Therapeutics, Inc. Sale 1,900 30.00 57,000
2017-03-27 BOLD Audentes Therapeutics, Inc. Sale 300 30.00 9,000
2017-12-01 BOLD Audentes Therapeutics, Inc. Option Ex 8,000 .79 6,320
2017-12-01 BOLD Audentes Therapeutics, Inc. Sale 8,000 28.72 229,744
2017-09-01 BOLD Audentes Therapeutics, Inc. Option Ex 8,000 .79 6,320
2017-09-01 BOLD Audentes Therapeutics, Inc. Sale 8,000 21.43 171,480

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Prasad Suyash (Senior VP & Chief Med Officer of Audentes Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.